Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | SCN4A | P35499 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 2/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3330660 | 1.00 | PRCP (0.45) | PRCPDPP7SCN4ANOS2NOS3 | |
| SCHEMBL10829027 | 1.00 | PRCP (0.45) | PRCPDPP7SCN4ANOS2NOS3 | |
| SCHEMBL133135 | 1.00 | PRCP (0.45) | PRCPDPP7SCN4ANOS2NOS3 | |
| Ammonia Solution, Strong SCHEMBL6516951 | 0.98 | PRCP (0.44) | PRCPDPP7SCN4ANOS2NOS3 | |
| Hydrochloric Acid SCHEMBL1073479 | 0.98 | PRCP (0.44) | PRCPDPP7SCN4ANOS2NOS3 | |
| Hydrochloric Acid SCHEMBL3530351 | 0.98 | PRCP (0.44) | PRCPDPP7SCN4ANOS2NOS3 | |
| Hydrochloric Acid SCHEMBL133134 | 0.98 | PRCP (0.44) | PRCPDPP7SCN4ANOS2NOS3 | |
| Azetidine SCHEMBL18917062 | 0.96 | PRCP (0.43) | PRCPDPP7SCN4ANOS2NOS3 | |
| SCHEMBL135813 | 0.94 | SLC6A2 (0.44) | PRCPSLC6A2SLC6A3SLC6A4ALDH1A1 | |
| SCHEMBL1929065 | 0.94 | SLC6A2 (0.44) | PRCPSLC6A2SLC6A3SLC6A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| CN-114560887-A | Preparation method of intermediate for preparing orlistat | 安徽美致诚药业有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-110099993-B | High impact perfume microcapsules of balanced density | 弗门尼舍有限公司 | 2021-08-24 | — | — | CN | claimed |
| CN-108660131-A | The preparation method of immobilization hydrating nitrile group enzyme and (S)-N- ethyl pyrrolidine -2- formamides | 浙江工业大学 | 2018-10-16 | — | — | CN | claimed |
| US-20140248270-A1 | METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS | YU RUEY J (US) | 2014-09-04 | — | — | US | claimed |
| US-20100093827-A1 | METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS | TRISTRATA, INC. (US) | 2010-04-15 | — | — | US | claimed |
| EP-1998788-A2 | COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS | Tristrata Inc. (US) | 2008-12-10 | — | — | EP | claimed |
| EP-1227820-B1 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2006-04-19 | — | — | EP | claimed |
| US-20040180854-A1 | Oligosaccharide aldonic acids and their topical use | YU RUEY J (US) | 2004-09-16 | — | — | US | claimed |
| US-6740327-B2 | USE FOR COSMETIC AND DERMATOLOGICAL INDICATIONS, REDUCING AND SOOTHING MUCOSA AND SKIN ERYTHEMA, INFLAMMATION OR REACTION CAUSED BY INTERNAL OR EXTERNAL FACTORS, WOUND HEALING, ETC. | YU RUEY J (US) | 2004-05-25 | — | — | US | claimed |
| EP-1227820-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | Yu, Ruey J., Dr. (US) | 2002-08-07 | — | — | EP | claimed |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | YU RUEY J (US) | 2002-03-07 | — | — | US | claimed |
| US-6335023-B1 | VEHICLES AND OLIGOSACCHARIDE ALDONIC ACIDS | YU RUEY J (US) | 2002-01-01 | — | — | US | claimed |
| WO-2001001932-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2001-01-11 | — | — | WO | claimed |
| EP-0188805-B1 | 1,3-DITHIOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-09-06 | — | — | EP | claimed |
| US-4737494-A | 2-YLIDENE AMMONIUM COMPOUNDS USED IN TREATING LIVER DISEASES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1988-04-12 | — | — | US | claimed |
| EP-0188805-A1 | 1,3-Dithiole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1986-07-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | GLA, ALDOA, MAN2A1 | PRCP 4316/4885DPP7 3192/4885SCN4A 3787/4885 |
| US-20040180854-A1 | Oligosaccharide aldonic acids and their topical use | GLA, ALDOA, MAN2A1 | PRCP 4316/4885DPP7 3192/4885SCN4A 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.